Here are examples of best practices in drug safety

December 2007
Clinical Trials Administrator;Dec2007, Vol. 5 Issue 12, p136
The article focuses on the on-site drug safety group employed by the Duke Clinical Research Institute (DCRI) at Duke University in Durham, North Carolina. It outlines the benefits of working with a drug safety group to clinical trial sites and research institutions. It cites the efforts by DCRI to make drug safety a major priority.


Related Articles

  • Drug safety has become an integral part of CT research from start to finish.  // Clinical Trials Administrator;Dec2007, Vol. 5 Issue 12, p133 

    The article focuses on the increasing attention paid to drug safety by pharmaceutical companies and clinical research institutions. It cites the move by research institutions and clinical research organizations in the U.S. and Europe to give more attention to pharmacovigilance by increasing...

  • 2009 Challenge: Innovate. Peters, Rita C. // Drug Discovery & Development;Jan2009, Vol. 12 Issue 1, p4 

    The article discusses various reports published within the issue, including one on the vital role of microsomes in screening new drugs and another on aspects of drug safety.

  • Safety checks for package tampering.  // Glamour;Sep92, Vol. 90 Issue 9, p142 

    Tells how to check medicine packaging for evidence of tampering. Reports that package labels list the safety seals to look for.

  • How safe is that drug?  // Pediatrics for Parents;1994, Vol. 15 Issue 7/8, p18 

    Reports on the efficacy and safety of drugs in children. Percent of drugs approved for prescription to children; Establishment of research sits to study drug safety and efficacy in children; National institute of Child Health and Development.

  • 'Atypical' Antidepressants in Overdose. Buckley, Nicholas A.; Faunce, Thomas A. // Drug Safety;Jun2003, Vol. 26 Issue 8, p539 

    Outlines a study published in the journal 'Drug Safety,' which found that tricyclic antidepressants appear to be associated with a greater risk of death in overdose than other antidepressant agents. Comparison of major features of the atypical antidepressants relevant to toxicity in overdose.

  • UMC signals go public.  // Reactions Weekly;2/18/2012, Issue 1389, p2 

    The article reports on the publication of signal articles that detail different levels of suspicions about postmarketing drug safety problems in the Uppsala Monitoring Center's "SIGNAL" document in 2012.

  • Device detects counterfeit drugs.  // Drug Topics;12/8/2003, Vol. 147 Issue 23, p14 

    Reports on the development of a device that will be primarily used to check the authenticity of drugs by the professors of two universities in the U.S.

  • A Decade of Data Mining and Still Counting. Hauben, Manfred; NorĂ©n, G. Niklas // Drug Safety;2010, Vol. 33 Issue 7, p527 

    The article discusses various reports on pharmacovigilance which are published within the issue including one by A. M. Hochberg and colleagues on three signal-detection algorithms, one by Y. Alvarez and colleagues on the validation of statistical signal detection procedures in Eudra Vigilance...

  • Warfarin fears as expansion looms.  // New Zealand Doctor;9/26/2012, p6 

    The article reports on the move of a general practitioner who contacted the New Zealand Medical Association (NZMA) to state his concern over the safety of the pharmacy warfarin management service.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics